Prosomnus IncNASDAQ:OSANASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.9800
- TODAY'S CHANGE (%)0.0200 (2.0833%)
- Bid / Lots0.9200/ 5
- Ask / Lots1.1200/ 10
- Open / Previous Close0.9501 / 0.9600
- Day Range
- 52 Week Range
- Volume3,259
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | OSA |
|---|---|---|
| 09:32 ET | 1522 | 0.975 |
| 11:22 ET | 800 | 0.98 |
| 11:31 ET | 400 | 0.98 |
| 03:59 ET | 251 | 0.98 |
Sep 26, 2023
DJ ProSomnus Is Maintained at Buy by Roth MKM, from 9:58AM ET on Tuesday Sep 26, 2023 by Dow Jones
9:58AM ET on Tuesday Sep 26, 2023 by Dow Jones
Sep 21, 2023
ProSomnus Raises $10 Million To Fuel Growth and Optimize Operations, from 8:30AM ET on Thursday Sep 21, 2023 by Dow Jones
8:30AM ET on Thursday Sep 21, 2023 by Dow JonesPress Release: ProSomnus Raises $10 Million To Fuel Growth and Optimize Operations, from 8:30AM ET on Thursday Sep 21, 2023 by Dow Jones
8:30AM ET on Thursday Sep 21, 2023 by Dow Jones
Sep 14, 2023
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Prosomnus Inc | 15.4M | -2.1x | --- |
Acutus Medical Inc | 19.6M | -0.5x | --- |
Micron Solutions Inc | 2.4M | -1.0x | --- |
InnerScope Hearing Technologies, Inc. | 7.8M | 0.0x | --- |
Ekso Bionics Holdings Inc | 10.1M | -0.6x | --- |
21st North Inc | 2.2K | 0.0x | --- |
Company Information
ProSomnus, Inc. is a medical technology company, which develops, manufactures and markets its proprietary line of precision intraoral medical devices for treating and managing patients with obstructive sleep apnea (OSA). The Company’s intraoral medical devices are engineered to track the treatment plan and anatomy of each patient. Its precision intraoral devices are Food and Drug Administration (FDA)-cleared, patented and covered by commercial medical insurance, Medicare, TRICARE and other Government-sponsored healthcare plans around the world, representing approximately 200 million covered lives. The Company’s products include ProSomnus EVO Sleep and Snore Device, ProSomnus EVO SELECT Sleep and Snore Device, ProSomnus EVO [PH] Sleep and Snore Device, ProSomnus [CA] LP Sleep and Snore Device and ProSomnus [MOG] Morning Occlusal Guide. The Company’s wholly owned subsidiaries include ProSomnus Holdings, Inc. and ProSomnus Sleep Technologies, Inc.
Contact Information
- Headquarters
- 5675 Gibraltar DrivePLEASANTON, CA, United States 94588
- Phone
- ---
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board
- Laing Rikkers
- Chief Executive Officer, Director
- Leonard Liptak
- Chief Financial Officer, Principal Accounting Officer
- Brian Dow
- Chief Technical Officer
- Sung Kim
- Vice President - Sales, North America
- Jerry Vogel
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $15.4M |
|---|---|
Revenue (TTM) | $23.5M |
Shares Outstanding | 16.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.47 |
Book Value | $-1.28 |
P/E Ratio | -2.1x |
Price/Sales (TTM) | 0.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -86.98% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
